Skip to main content
. 2024 Jan 19;110(3):1663–1676. doi: 10.1097/JS9.0000000000001047

Table 1.

Demographic and clinical characteristics of patients stratified by 3D-RVT assessment use.

The entire cohort The PSM cohort The stabilized IPTW cohort
Characteristics 3D group (n=1681) 2D group (n=1721) SMD P 3D group (n=892) 2D group (n=892) SMD P 3D group (n=1608.3) 2D group (n=1777.8) SMD P
Age (year)a 54.0 (45.0–61.0) 55.0 (47.0–63.0) 0.111 0.002 54.0 (45.0–62.0) 54.0 (45.0–62.0) 0.018 0.708 54.0 (46.0–61.0) 54.0 (45.0–62.0) 0.011 0.206
Sex, male 1267 (75.4) 1457 (84.7) 0.234 <0.001 702 (78.7) 716 (80.3) 0.036 0.412 1286.0 (80.0) 1419.3 (79.8) 0.003 0.932
Hepatitis 1054 (62.7) 1351 (78.5) 0.352 <0.001 631 (70.7) 635 (71.2) 0.009 0.835 1123.7 (69.9) 1252.5 (70.5) 0.013 0.707
Cirrhosis 811 (48.2) 724 (42.1) 0.124 <0.001 420 (47.1) 409 (45.9) 0.025 0.602 721.2 (44.8) 777.9 (43.8) 0.022 0.533
Child-Pugh 0.017 0.629 0.000 1.000 0.017 0.655
 Class A 1669 (99.3) 1711 (99.4) 887 (99.4) 887 (99.4) 1597.9 (99.4) 1768.6 (99.5)
 Class B 12 (0.7) 10 (0.6) 5 (0.6) 5 (0.6) 10.4 (0.6) 9.2 (0.5)
AFP (ng/ml) 0.378 <0.001 0.041 0.375 0.034 0.351
 <400 940 (55.9) 1268 (73.7) 560 (62.8) 578 (64.8) 1019.9 (63.4) 1156.3 (65.0)
 ≥400 741 (44.1) 453 (26.3) 332 (37.2) 314 (35.2) 588.4 (36.6) 621.5 (35.0)
ALT (U/l) 0.368 <0.001 0.027 0.550 0.026 0.456
 <45 994 (59.1) 1309 (76.1) 580 (65.0) 592 (66.4) 1009.0 (62.7) 1092.8 (61.5)
 ≥45 687 (40.9) 412 (23.9) 312 (35.0) 300 (33.6) 599.3 (37.3) 685.0 (38.5)
TBIL (μmol/l) 0.159 <0.001 0.036 0.453 0.008 0.827
 <17.5 1160 (69.0) 1058 (61.5) 598 (67.0) 583 (65.4) 1059.5 (65.9) 1177.6 (66.2)
 ≥17.5 521 (31.0) 663 (38.5) 294 (33.0) 309 (34.6) 548.8 (34.1) 600.2 (33.8)
ALB (g/l) 0.204 <0.001 0.056 0.280 0.003 0.963
 <35 194 (11.5) 324 (18.8) 120 (13.5) 136 (15.2) 265.3 (16.5) 291.3 (16.4)
 ≥35 1487 (88.5) 1397 (81.2) 772 (86.5) 756 (84.8) 1343.0 (83.5) 1486.5 (83.6)
Hb (g/l) 0.106 0.002 0.000 1.000 0.027 0.491
 <100 92 (5.5) 57 (3.3) 35 (3.9) 35 (3.9) 80.6 (5.0) 99.8 (5.6)
 ≥100 1589 (94.5) 1664 (96.7) 857 (96.1) 857 (96.1) 1527.7 (95.0) 1677.9 (94.4)
PLT (×109/l) 0.220 <0.001 0.042 0.277 0.006 0.896
 <100 157 (9.3) 67 (3.9) 60 (6.7) 49 (5.5) 118.8 (7.4) 134.0 (7.5)
 ≥100 1524 (90.7) 1654 (96.1) 832 (93.3) 843 (94.5) 1489.5 (92.6) 1643.8 (92.5)
PT (s) 0.144 <0.001 0.011 0.827 0.004 0.938
 <13.5 1338 (79.6) 1265 (73.5) 666 (74.7) 670 (75.1) 1172.2 (72.9) 1292.4 (72.7)
 ≥13.5 343 (20.4) 456 (26.5) 226 (25.3) 222 (24.9) 436.1 (27.1) 485.4 (27.3)
Surgical type 0.501 <0.001 0.057 0.194 0.024 0.507
 LH 676 (40.2) 312 (18.1) 274 (30.7) 249 (27.9) 506.6 (31.5) 579.6 (32.6)
 OH 1005 (59.8) 1409 (81.9) 618 (69.3) 643 (72.1) 1101.7 (68.5) 1198.2 (67.4)
Type of hepatectomy 0.620 <0.001 0.010 0.856 0.061 0.079
 AR 1475 (87.7) 1068 (62.1) 722 (80.9) 725 (81.3) 1258.2 (78.2) 1345.3 (75.7)
 NAR 206 (12.3) 653 (37.9) 170 (19.1) 167 (18.7) 350.1 (21.8) 432.5 (24.3)
Extent of hepatectomyb 0.855 <0.001 0.000 1.000 0.037 0.299
 Major 1234 (73.4) 589 (34.2) 530 (59.4) 530 (59.4) 904.1 (56.2) 966.8 (54.4)
 Minor 447 (26.6) 1132 (65.8) 362 (40.6) 362 (40.6) 704.2 (43.8) 811.0 (45.6)
Diameter (cm)c 0.153 <0.001 0.025 0.600 0.004 0.918
 <5 712 (42.4) 860 (50.0) 392 (43.9) 403 (45.2) 743.6 (46.2) 818.3 (46.0)
 ≥5 969 (57.6) 861 (50.0) 500 (56.1) 489 (54.8) 864.7 (53.8) 959.5 (54.0)
Tumor number 0.269 <0.001 0.048 0.397 0.002 0.963
 Single 1506 (89.6) 1377 (80.0) 759 (85.1) 746 (83.6) 1349.0 (83.9) 1492.4 (83.9)
 Multiple 175 (10.4) 344 (20.0) 133 (14.9) 146 (16.4) 259.3 (16.1) 285.4 (16.1)
Differentiation 0.204 <0.001 0.023 0.643 0.033 0.349
 Well-moderate 1255 (74.7) 1125 (65.4) 625 (70.1) 616 (69.1) 1133.3 (70.5) 1226.0 (69.0)
 Poor 426 (25.3) 596 (34.6) 267 (29.9) 276 (30.9) 475.0 (29.5) 551.8 (31.0)
MVI 0.156 <0.001 0.019 0.695 0.038 0.285
 Negative 1104 (65.7) 1000 (58.1) 559 (62.7) 567 (63.6) 1027.0 (63.9) 1102.5 (62.0)
 Positive 577 (34.3) 721 (41.9) 333 (37.3) 325 (36.4) 581.3 (36.1) 675.3 (38.0)

Values in parentheses are percentages unless indicated otherwise.

a

Values are median (i.q.r.).

b

Major liver resection was defined as removal of three or more liver segments.

c

Diameter refers to the maximum tumor diameter that can be obtained at the time of preoperative evaluation.

2D, two-dimensional; 3D, three-dimensional; 3D-RVT, three-dimensional reconstruction visualization technology; AFP, α-fetoprotein; ALB, albumin; ALT, alanine aminotransferase; AR, anatomical resection; Hb, hemoglobin; IPTW, inverse probability of treatment weighting; LH, laparoscopic hepatectomy; MVI, microvascular invasion; NAR, nonanatomical resection; OH, open hepatectomy; PLT, platelet; PSM, propensity score matching; PT, prothrombin time; SMD, standardized mean difference; TBIL, total bilirubin.